Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
The Journal of Infectious Diseases
|
February 11, 2000
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team
D R Kuritzkes, A Sevin, B Young, et al.
The American Review of Respiratory Disease
|
February 1, 1987
Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients
R A Salata, M M Lederman, D M Shlaes, et al.
Archives of Internal Medicine
|
April 1, 1989
Tendency to serious sequelae of infection with the human immunodeficiency virus in sibships with hemophilia
N J Meropol, P R Krause, O D Ratnoff, et al.
Medicine
|
May 1, 1986
Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature
M Wieland, M M Lederman, C Kline-King, et al.
The Journal of Infectious Diseases
|
April 14, 2000
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853
R D MacArthur, M M Lederman, C A Benson, et al.
The Journal of Infectious Diseases
|
June 1, 1995
High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group
B J Dezube, M M Lederman, J G Spritzler, et al.
The Journal of Infectious Diseases
|
November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team
R H Haubrich, C Flexner, M M Lederman, et al.
The Journal of Infectious Diseases
|
December 23, 1999
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy
K Y Smith, H Valdez, A Landay, et al.
AIDS (London, England)
|
July 23, 1999
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication
A H Patki, S F Purvis, H Valdez, et al.
AIDS (London, England)
|
March 29, 2001
Placebo-controlled trial of prednisone in advanced HIV-1 infection
G A McComsey, C C Whalen, S D Mawhorter, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
The Journal of Infectious Diseases
|
February 11, 2000
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team
D R Kuritzkes, A Sevin, B Young, et al.
The American Review of Respiratory Disease
|
February 1, 1987
Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients
R A Salata, M M Lederman, D M Shlaes, et al.
Archives of Internal Medicine
|
April 1, 1989
Tendency to serious sequelae of infection with the human immunodeficiency virus in sibships with hemophilia
N J Meropol, P R Krause, O D Ratnoff, et al.
Medicine
|
May 1, 1986
Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature
M Wieland, M M Lederman, C Kline-King, et al.
The Journal of Infectious Diseases
|
April 14, 2000
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853
R D MacArthur, M M Lederman, C A Benson, et al.
The Journal of Infectious Diseases
|
June 1, 1995
High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group
B J Dezube, M M Lederman, J G Spritzler, et al.
The Journal of Infectious Diseases
|
November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team
R H Haubrich, C Flexner, M M Lederman, et al.
The Journal of Infectious Diseases
|
December 23, 1999
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy
K Y Smith, H Valdez, A Landay, et al.
AIDS (London, England)
|
July 23, 1999
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication
A H Patki, S F Purvis, H Valdez, et al.
AIDS (London, England)
|
March 29, 2001
Placebo-controlled trial of prednisone in advanced HIV-1 infection
G A McComsey, C C Whalen, S D Mawhorter, et al.
Page
of 14